IP Library Assignment 054704/0830
Patent Assignment
Reel/Frame 054704/0830

Merger and Change of Name

Recorded: 2020-12-21 Pages: 3
Assignors
VGX PHARMACEUTICALS, INC.
Executed: 2009-06-01
INOVIO ACQUISITION, LLC
Executed: 2009-06-01
Assignee
VGX PHARMACEUTICALS, LLC
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PENNSYLVANIA, 19462
Covered Properties (16)
Treating Anemia in Subjects by Administration of Plasmids Encoding Growth Hormone Releasing Hormone
Patent: 7,241,744 →
Application: 10/315,907 →
Publication: US 2004/0057941
Electrode Assembly for Constant-Current Electroporation and Use
Patent: 7,245,963 →
Application: 10/360,768 →
Publication: US 2004/0167458
Codon Optimized Synthetic Plasmids
Patent: 7,316,925 →
Application: 10/619,939 →
Publication: US 2004/0092009
Constant Current Electroporation Device and Methods of Use
Patent: 8,209,006 →
Application: 10/657,725 →
Publication: US 2005/0052630
Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
Patent: 8,481,504 →
Application: 10/798,896 →
Publication: US 2005/0238624
Canine Specific Growth Hormone Releasing Hormone
Patent: 7,361,642 →
Application: 10/894,644 →
Publication: US 2005/0032737
Reducing Arthritis and Lameness in Subjects by Growth Hormone Releasing Hormone (Ghrh) Supplementation
Patent: 8,188,056 →
Application: 11/015,935 →
Publication: US 2005/0182014
Enhanced Secretion / Retention of Growth Hormone Releasing Hormone (Ghrh) from Muscle Cells by Species-Specific Signal Peptide
Patent: 7,517,863 →
Application: 11/034,682 →
Publication: US 2005/0171046
Optimized High Yield Synthetic Plasmids
Patent: 7,846,720 →
Application: 11/339,894 →
Publication: US 2006/0188988
Electrode Assembly for Constant-Current Electroporation and Use
Patent: 7,664,545 →
Application: 11/495,021 →
Publication: US 2006/0264807
Gene Therapy Expression of Ghrh for Increasing Rbc Count in Subjects
Patent: 8,178,504 →
Application: 11/726,291 →
Publication: US 2009/0170748
Electroporation Devices and Methods of Using Same for Electroporation of Cells in Mammals
Patent: 9,452,285 →
Application: 11/874,072 →
Publication: US 2008/0091135
Antibody Production Elicited by a Dna Vaccine Delivered by Electroporation
Patent: 8,927,508 →
Application: 12/271,603 →
Publication: US 2009/0156787
Growth Hormone Releasing Hormone Treatment to Decrease Cholesterol Levels
Patent: 8,058,253 →
Application: 12/307,733 →
Publication: US 2010/0010467
COMPOSITIONS COMPRISING GHRH AND GnRH AND METHODS OF USING THE SAME
Patent: 8,962,818 →
Application: 12/920,545 →
Publication: US 2011/0034544
Optimized High Yield Synthetic Plasmids
Patent: 8,563,302 →
Application: 12/948,061 →
Publication: US 2011/0070640
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 9, 2012
From: SCHWARTZ, ROBERT J; BRENNER, MALCOLM K
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 028011/0255 →
Assignment of Assignor's Interest Apr 9, 2012
From: DRAGHIA-AKLI, RUXANDRA; CARPENTER, ROBERT H; KERN, DOUGLAS R; KING, GLEN
To: ADVISYS INC.
Reel/Frame 028011/0207 →
Merger Apr 9, 2012
From: ADVISYS INC.
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 028011/0311 →
Merger Sep 3, 2013
From: ADVISYS INC.
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 031124/0710 →
Assignment of Assignor's Interest Sep 3, 2013
From: DRAGHIA=AKLI, RUXANDRA; POPE, MELISSA
To: ADVISYS, INC.
Reel/Frame 031124/0609 →
Assignment of Assignor's Interest Jan 9, 2015
From: DRAGHIA-AKLI, RUXANDRA; BROWN, PATRICIA; KHAN, AMIR
To: VGX PHARMACEUTICALS, INC
Reel/Frame 034670/0220 →
Merger Feb 2, 2021
From: VGX PHARMACEUTICALS, LLC
To: INOVIO PHARMACEUTICALS, INC.
Reel/Frame 055114/0843 →